Table 1 Patient characteristics according to ABC use
| Â | ABC-containing regimen | Non-ABC-containing regimen |
|---|---|---|
Number of patients (% male) | 27 (89) | 54 (89) |
Age (years) | 48 ± 11 | 47 ± 10 |
Ethnicity | Â | Â |
   Caucasian (%) | 23 (85) | 43 (80) |
   African-American (%) | 1 (4) | 4 (7) |
   Asian (%) | 2 (7) | 4 (7) |
   Other (%) | 1 (4) | 3 (6) |
Current smoker (%) | 13 (48) | 19 (35) |
Chronic hepatitis C infection (%) | 2 (7) | 4 (7) |
Chronic hepatitis B infection (%) | 1 (4) | 1 (2) |
History of cardiovascular event (%) | 1 (4) | - |
Total duration of cART use (months) | 116 (85-129)* | 91 (33-121) |
Total time on ABC (months) | 68 (59-80) | - |
cART regimen | Â | Â |
   ABC + other NRTI (%) | 11 (41) | - |
   ABC + PI (%) | 7 (26) | - |
   ABC + NNRTI (%) | 9 (33) | - |
   non-ABC + PI (%) | - | 27 (50) |
   non-ABC + NNRTI (%) | - | 27 (50) |
CD4 cell count (cells/mm3) | 490 (310-770) | 530 (300-720) |
HIV viral load <40 copies/ml (%) | 23 (85) | 46 (85) |
Duration HIV viral load <40 copies/ml (months) | 90 (72-113) | 68 (22-120) |
Total cholesterol (mmol/L) | 5.0 ± 0.9 | 5.0 ± 1.0 |
Triglycerides (mmol/L) | 2.5 ± 1.9 | 2.2 ± 1.7 |
Non-fasting glucose (mmol/L) | 6.1 ± 1.2 | 5.9 ± 1.5 |
Use of antihypertensive drugs (%) | 2 (7) | 7 (13) |
Use of statins (%) | 7 (26) | 6 (11) |
Use of oral antidiabetics (%) | 1 (4) | 0 (-) |